Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01G
- Chemical subgroupJ01GB
- Chemical substanceJ01GB01Tobramycin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 60 registrations
- BramitobChiesi Farmacêutica Ltda
- TobracinCristália Produtos Químicos Farmacêuticos Ltda.
- TobracularLegrand Pharma Indústria Farmacêutica Ltda
- TobraloxEms S/A
Canada
Health Canada · 35 registrations
- Sandoz Tobramycin0.3 % · Solution · Sandoz Canada Incorporated
- Teva-Tobramycin60 MG / ML · Solution · Teva Canada Limited
- Tobi300 MG / 5 ML · Solution · BGP Pharma Ulc
- Tobi Podhaler28 MG · Capsule · BGP Pharma Ulc
At a glance
- ATC code
- J01GB01
- ATC group
- Anti-infectives for systemic use
- Registers
- 11
- Historical lists
- 2
- Registrations
- 208
- With their own page
- 113
- Companies
- 98
All medicines with Tobramycin
Human medicines from every register that match Tobramycin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
207 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tobramycin | United States | 300MG/4ML, 300MG/5ML | solution | Marketed | Amneal Pharms |
| Tobramycin | United States | 0.3% | solution/drops | Marketed | Somerset Theraps LLC |
| Tobramycin Sulfate | United States | 1.2GM BASE/VIAL, 10MG BASE/ML, 40MG BASE/ML | injectable | Marketed | Hospira |
| Tobramycin BNM | New Zealand | Solution for inhalation 60 mg per ml, 5 ml | Funded | ||
| Tobramycin and DexamethasoneCombination | United States | 0.1%; 0.3% | suspension/drops | Marketed | Amneal |
| Tobramycin Sulfate (Pharmacy Bulk) | United States | 40MG BASE/ML, 40MG BASE/ML | injectable | Marketed | Fresenius Kabi USA |
| Tobramycin for Injection | Canada | 1.2 G / VIAL | Powder For Solution | Marketed | Fresenius Kabi Canada LTD |
| Tobramycin Injection USP | Canada | 40 MG / ML | Solution | Marketed | Jamp Pharma Corporation |
| Tobramycin Injection USP | Canada | 40 MG / ML | Solution | Marketed | Sandoz Canada Incorporated |
| Tobramycin Injection USP | Canada | 40 MG / ML | Solution | Marketed | Sterimax INC |
| Tobramycin Injection, USP | Canada | 40 MG / ML | Solution | Marketed | Fresenius Kabi Canada LTD |
| Tobramycin Injection USP | Canada | 10 MG / ML | Solution | Marketed | Sandoz Canada Incorporated |
| Tobramycin (Viatris) | New Zealand | Inj 40 mg per ml, 2 ml vial | Funded | ||
| Tobramycin Injection USP | Canada | 10 MG / ML | Solution | Authorised | Sterimax INC |
| Tobramycin Inhalation Solution USP | Canada | 300 MG / 5 ML | Solution | Authorised | Laboratoire Riva INC. |
| Tobramycine CF 40 mg/ml, injectievloeistof | Netherlands | Oplossing voor injectie | Authorised | Centrafarm B.V. | |
| Tobramycine SUN 300 mg/5 ml verneveloplossing | Netherlands | Verneveloplossing | Authorised | Sun Pharmaceutical Industries Europe B.V. | |
| Tobramycine Aristo, 300 mg/5 ml verneveloplossing | Netherlands | Verneveloplossing | Authorised | Aristo Pharma GmbH | |
| Tobramycine Steri-Neb 300 mg/5 ml, verneveloplossing | Netherlands | Verneveloplossing | Authorised | Teva Nederland B.V. | |
| Tobramycine Steri-Neb 300 mg/5 ml, verneveloplossing | Netherlands | Verneveloplossing | Authorised | Euro Registratie Collectief B.V. | |
| Teva-Tobramycin | Canada | 60 MG / ML | Solution | Marketed | Teva Canada Limited |
| Tobramycin for Injection USP | Canada | 1.2 G / VIAL | Powder For Solution | Not marketed | Sterimax INC |
| Tobramycine + Dexamethason Blumont 3 mg/ml + 1 mg/ml, oogdruppels, suspensieCombination | Netherlands | Oogdruppels, suspensie | Authorised | Blumont Ofta Trading Limited | |
| Sandoz Tobramycin | Canada | 0.3 % | Solution | Marketed | Sandoz Canada Incorporated |
| Tobramycin Sulfate in Sodium Chloride 0.9% in Plastic Container | United States | 1.2MG BASE/ML, 1.6MG BASE/ML, 80MG BASE/100ML | injectable | Not marketed | Hospira |